Legend Biotech (LEGN) Current Leases (2019 - 2025)
Historic Current Leases for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $7.4 million.
- Legend Biotech's Current Leases rose 6982.96% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 6982.96%. This contributed to the annual value of $4.8 million for FY2024, which is 5099.21% up from last year.
- Legend Biotech's Current Leases amounted to $7.4 million in Q3 2025, which was up 6982.96% from $5.9 million recorded in Q2 2025.
- Over the past 5 years, Legend Biotech's Current Leases peaked at $7.4 million during Q3 2025, and registered a low of $1673.0 during Q1 2021.
- Its 5-year average for Current Leases is $3.5 million, with a median of $3.6 million in 2023.
- Per our database at Business Quant, Legend Biotech's Current Leases crashed by 3777.32% in 2021 and then soared by 21807095.04% in 2022.
- Legend Biotech's Current Leases (Quarter) stood at $911000.0 in 2021, then skyrocketed by 291.11% to $3.6 million in 2022, then decreased by 10.89% to $3.2 million in 2023, then skyrocketed by 50.99% to $4.8 million in 2024, then skyrocketed by 53.82% to $7.4 million in 2025.
- Its Current Leases was $7.4 million in Q3 2025, compared to $5.9 million in Q2 2025 and $5.3 million in Q1 2025.